- Home
- CPHC vs ONCY Comparison
CPHC vs ONCY Comparison
Compare CPHC & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPHC | ONCY |
|---|---|---|
| Founded | 1994 | 1998 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Pharmaceuticals and Biotechnology |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.3M | 94.0M |
| IPO Year | 2016 | 2002 |
Fundamental Metrics
Financial Performance| Metric | CPHC | ONCY |
|---|---|---|
| Price | $15.62 | $1.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 1.4K | ★ 1.7M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 1.81% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $59,227,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 0.14 | N/A |
| 52 Week Low | $14.49 | $0.33 |
| 52 Week High | $21.61 | $1.51 |
Technical Indicators
Market Signals| Indicator | CPHC | ONCY |
|---|---|---|
| Relative Strength Index (RSI) | 51.19 | 52.41 |
| Support Level | $15.06 | $0.87 |
| Resistance Level | $16.02 | $1.13 |
| Average True Range (ATR) | 0.29 | 0.10 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 64.02 | 62.26 |
Price Performance
Historical ComparisonAbout CPHC Canterbury Park Holding Corporation 'New'
Canterbury Park Holding Corp is in the business of pari-mutuel wagering on horse races and unbanked card games at its canterbury park racetrack and card casino facility in Minnesota. The company has four operating segments. The horse racing segment represents pari-mutuel wagering operations on simulcast and lives horse races; the Casino segment represents unbanked card operations; the food and beverage segment includes concessions, catering, and events services provided at the Racetrack; and the development segment represents its real estate development operations. The firm generates a majority of its revenue from the Casino segment.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.